Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Clinical trial NCT05341349 · TERMINATED

Trial details

NCT number: NCT05341349
Sponsor: Emory University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical Stage IV Cutaneous Melanoma AJCC v8 Melanoma of Unknown Primary Metastatic Malignant Neoplasm in the Brain Metastatic Melanoma Metastatic Mucosal Melanoma Metastatic Ocular Melanoma Pathologic Stage IV Cutaneous Melanoma AJCC v8

Start date: 2022-10-13
Primary completion: 2024-05-31
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.